Ibritumomab Intravenous and Zolpidem Sublingual Tablets (Intermezzo)
Determining the interaction of Ibritumomab Intravenous and Zolpidem Sublingual Tablets (Intermezzo) and the possibility of their joint administration.
No interaction was detected between the selected drugs or effects of joint drug administration are currently understudied, and it takes time and accumulated statistics to determine their interaction. A doctor should be consulted to address the issue of joint drug administration.
Generic Name: ibritumomab
Brand name: Y-90 Zevalin, In-111 Zevalin
Synonyms: Ibritumomab, Ibritumomab Tiuxetan
Generic Name: zolpidem
Brand name: Ambien, Ambien CR, Edluar, Intermezzo, ZolpiMist
Synonyms: Zolpidem
In the course of checking the drug compatibility and interactions, data from the following reference sources was used: Drugs.com, Rxlist.com, Webmd.com, Medscape.com.
- Ibritumomab Intravenous-Zolpidem Tablets
- Ibritumomab Intravenous-Zolpidem Tartrate
- Ibritumomab Intravenous-ZolpiMist
- Ibritumomab Intravenous-Zolvit
- Ibritumomab Intravenous-Zomacton
- Ibritumomab Intravenous-Zometa
- Zolpidem Sublingual Tablets (Intermezzo)-Ibritumomab Tiuxetan
- Zolpidem Sublingual Tablets (Intermezzo)-Ibrutinib
- Zolpidem Sublingual Tablets (Intermezzo)-Ibrutinib Capsules
- Zolpidem Sublingual Tablets (Intermezzo)-Ibrutinib Tablets
- Zolpidem Sublingual Tablets (Intermezzo)-Ibu
- Zolpidem Sublingual Tablets (Intermezzo)-IBU Tablets